| Efficacy on systolic and diastolic blood pressure decrease and safety of once-a-day oral 5 mg Perindopril arginine salt (titrated to 10 mg). | Efficacy on systolic and diastolic blood pressure decrease and safety of once-a-day oral 5 mg Perindopril arginine salt (titrated to 10 mg). A 12-week, 2-arm, randomised, double-blind study versus once-a-day oral 4 mg perindopril tert-butylamine salt (titrated to 2 x 4 mg) in hypertensive patients. | ChiCTR-TRC-12001961 |
| A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on an Empty Stomach in Healthy Subjects | Bioequivalence Study of Fasting Oral Perindopril Tert-butylamine Tablets in Healthy Subjects With a Single-dose, Randomized, Open, Two-cycle, Crossover Trial Design | NCT04556058 |
| A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on After Meals in Healthy Subjects | Bioequivalence Study of Oral Perindopril Tert-butylamine Tablets After Meal in Healthy Subjects With a Single-dose, Randomized, Open-lable, Four-cycle, Crossover Trial Design | NCT04556110 |
| Efficacy and safety of the fixed oral perindopril arginine 5 mg/ amlopidine 5 mg combination compared with perindopril tert-butylamine 4 mg alone in patients not adequately controlled with perindopril tert-butylamine 4 mg monotherapy. | Efficacy and safety of the fixed oral perindopril arginine 5 mg/ amlopidine 5 mg combination compared with perindopril tert-butylamine 4 mg alone in patients not adequately controlled with perindopril tert-butylamine 4 mg monotherapy. A randomised double blind 12 weeks study with up titration after | ChiCTR-TRC-12001986 |
